Cargando…

Effects of preoperative serum lactate dehydrogenase levels on long-term prognosis in elderly patients with hepatocellular carcinoma undergoing transcatheter arterial chemoembolization

Hepatic arterial chemoembolization is an effective treatment for primary hepatocellular carcinoma (HCC) and can improve the survival rate of patients. Nevertheless, the long-term prognosis of patients with HCC is not optimistic. In recent years, tumor humoral detection has attracted extensive attent...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gan, Yuantao, Gao, Fengwei, Du, Bo, Liu, Yu, Xue, Qian, Fu, Jinqiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Surgery
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9539260/ https://www.ncbi.nlm.nih.gov/pubmed/36211260 http://dx.doi.org/10.3389/fsurg.2022.982114

Ejemplares similares

Serum T Cell Immunoglobulin Mucin 3 Predicts Worse Prognosis in Hepatocellular Carcinoma Patients Undergoing Transcatheter Arterial Chemoembolization
por: Li, Jun, et al.
Publicado: (2022)

Meta-analysis: preoperative transcatheter arterial chemoembolization does not improve prognosis of patients with resectable hepatocellular carcinoma
por: Zhou, Yanming, et al.
Publicado: (2013)

Gastric transcatheter chemoembolization can resolve advanced gastric cancer presenting with obstruction
por: Peng, Dong, et al.
Publicado: (2022)

Therapeutic effect of postoperative adjuvant transcatheter arterial chemoembolization based on the neutrophil-to-lymphocyte ratio
por: Feng, Guo-Ying, et al.
Publicado: (2023)

Preoperative transcatheter arterial chemoembolization and prognosis of patients with solitary large hepatocellular carcinomas (≥5 cm): Multicenter retrospective study
por: Mo, Ali, et al.
Publicado: (2022)

Resection versus Resection with Preoperative Transcatheter Arterial Chemoembolization for Resectable Hepatocellular Carcinoma Recurrence
por: Tao, Qiang, et al.
Publicado: (2018)

Preoperative Versus Postoperative Transarterial Chemoembolization on Prognosis of Large Hepatocellular Carcinoma
por: Wang, Xiaohui, et al.
Publicado: (2021)

Impact of lactate dehydrogenase on prognosis of patients undergoing cardiac surgery
por: Zeng, Yu, et al.
Publicado: (2022)

Meta-analysis of serum lactate dehydrogenase and prognosis for osteosarcoma
por: Fu, Yucheng, et al.
Publicado: (2018)

The value of lactate dehydrogenase to albumin ratio and immune inflammation biomarkers in colorectal cancer
por: Wu, Jiali, et al.
Publicado: (2023)

Clinical Nursing Paths Benefit Patient Outcomes Undergoing Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma
por: Gu, Jing, et al.
Publicado: (2022)

Arterial chemoembolization for patients with hepatocellular carcinoma and elevated lactate dehydrogenase is associated with low survival: a cohort study
por: Zhuang, Genghui, et al.
Publicado: (2022)

Pulmonary complications of transcatheter arterial chemoembolization for hepatocellular carcinoma
por: Nhu, Quan M, et al.
Publicado: (2016)

Balloon-occluded transcatheter arterial chemoembolization for hepatocellular carcinoma
por: Hatanaka, Takeshi, et al.
Publicado: (2018)

Transarterial Chemoembolization Combined With Radiofrequency Ablation Versus Hepatectomy for Hepatocellular Carcinoma: A Meta-Analysis
por: Dan, Yuan, et al.
Publicado: (2022)

Meta-analysis of transcatheter arterial chemoembolization plus radiofrequency ablation versus transcatheter arterial chemoembolization alone for hepatocellular carcinoma
por: Yang, De-jun, et al.
Publicado: (2016)

Transcatheter Arterial Chemoembolization for Intermediate-Stage Hepatocellular Carcinoma: Clinical Outcome and Safety in Elderly Patients
por: Nishikawa, Hiroki, et al.
Publicado: (2014)

ASPP2 expression predicts the prognosis of patients with hepatocellular carcinoma after transcatheter arterial chemoembolization
por: Mao, Jiaren, et al.
Publicado: (2021)

Analysis of factors affecting the prognosis of transcatheter arterial chemoembolization for hepatitis B-related hepatocellular carcinoma
por: Cun, Jiangping, et al.
Publicado: (2021)

Retracted: Clinical Nursing Paths Benefit Patient Outcomes Undergoing Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)

Drug-eluting Bead-Transcatheter Arterial Chemoembolization for Advanced Hepatocellular Carcinoma Refractory to Conventional Lipiodol-based Transcatheter Arterial Chemoembolization
por: Kobayashi, Saito, et al.
Publicado: (2020)

Serum YKL-40 Independently Predicts Outcome after Transcatheter Arterial Chemoembolization of Hepatocellular Carcinoma
por: Zhu, Cheng-Bao, et al.
Publicado: (2012)

Transcatheter Arterial Chemoembolization Based on Hepatic Hemodynamics for Hepatocellular Carcinoma
por: Murata, Satoru, et al.
Publicado: (2013)

Transcatheter Arterial Chemoembolization Therapy for Patients With Unresectable Hepatocellular Carcinoma
por: Firouznia, Kavous, et al.
Publicado: (2014)

Hepatogastric Fistula following Transcatheter Arterial Chemoembolization of Hepatocellular Carcinoma
por: Grover, Inderpreet, et al.
Publicado: (2014)

The radiological prognostic factors of transcatheter arterial chemoembolization to hepatocellular carcinoma
por: Lee, Shou-Wu, et al.
Publicado: (2022)

Multifunctional nanoplatforms application in the transcatheter chemoembolization against hepatocellular carcinoma
por: Yuan, Gang, et al.
Publicado: (2023)

Lipiodol Pneumonitis Following Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma
por: Kim, Sungkeun, et al.
Publicado: (2020)

Texture analysis of intermediate-advanced hepatocellular carcinoma: prognosis and patients' selection of transcatheter arterial chemoembolization and sorafenib
por: Fu, Sirui, et al.
Publicado: (2016)

Serum lactate dehydrogenase level predicts the prognosis in bladder cancer patients
por: Gu, Shuo, et al.
Publicado: (2023)

Transcatheter arterial chemoembolization plus sorafenib versus transcatheter arterial chemoembolization alone to treat advanced hepatocellular carcinoma: a meta-analysis
por: Cai, Rong, et al.
Publicado: (2017)

The efficiency of pathological response after preoperative transcatheter arterial chemoembolization for microvascular invasion and early tumor recurrence in hepatocellular carcinoma
por: He, Tao, et al.
Publicado: (2022)

Prognostic Significance of Tumor Growth Rate (TGR) in Patients with Huge Hepatocellular Carcinoma Undergoing Transcatheter Arterial Chemoembolization
por: Chen, Guobin, et al.
Publicado: (2022)

The Significance of the preoperative lactate dehydrogenase/albumin Ratio in the Prognosis of Colon Cancer: a retrospective study
por: Xie, Zhihui, et al.
Publicado: (2022)

The priority of liver resection compared with transarterial chemoembolization in hepatocellular carcinoma at BCLC B1 stage: A single-center experience
por: Yi, Peng-Sheng, et al.
Publicado: (2022)

Transcatheter arterial chemoembolization monotherapy vs combined transcatheter arterial chemoembolization–percutaneous microwave coagulation therapy for massive hepatocellular carcinoma (≥10 cm)
por: Wei, Yanyan, et al.
Publicado: (2018)

Quality of Life after Transcatheter Arterial Chemoembolization Combined with Radiofrequency Ablation in Patients with Unresectable Hepatocellular Carcinoma Compared with Transcatheter Arterial Chemoembolization alone
por: Hassanin, Taha M, et al.
Publicado: (2021)

The correlation with tumor radiological characteristics and prognosis of patients with early-stage hepatocellular carcinoma receiving transcatheter arterial chemoembolization
por: Lee, Shou-Wu, et al.
Publicado: (2021)

Pulmonary lipiodol embolism after transcatheter arterial chemoembolization for hepatocellular carcinoma
por: Lin, Ming-Tzer, et al.
Publicado: (2010)

Comparison of the efficacy of transcatheter arterial chemoembolization and sorafenib for advanced hepatocellular carcinoma
por: NISHIKAWA, HIROKI, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_mps2sgdkqeidul97n697foiao6